Safety of prophylactic use of darbepoetin alfa in patients with diffuse large B-Cell lymphoma (DLBCL) treated with R-CHOP 14 or RCHOP21: Preliminary results of the LNH03-6B randomized GELA study.

Delarue, R.; Mounier, N.; Haioun, C.; Coiffier, B.; Gisselbrecht, C.; Ghesquieres, H.; Lederlin, P.; Blanc, M.; Recher, C.; Hermine, O.; Reyes, F.; Tilly, H.; Bosly, André

Safety of prophylactic use of darbepoetin alfa in patients with diffuse large B-Cell lymphoma (DLBCL) treated with R-CHOP 14 or RCHOP21: Preliminary results of the LNH03-6B randomized GELA study.

Delarue, R.

;

Mounier, N.

;

Haioun, C.

;

Coiffier, B.

;

Bosly, André

;et.al.

(2006) 48th Annual Meeting of the American-Society-of-Hematology — Location: Orlando(Fl) (9.December.2006)

Files

No attached file found for this publication.

Details

Authors

Delarue, R.
Author
Mounier, N.
Author
Haioun, C.
Author
Coiffier, B.
Author
Bosly, AndréUCLouvain
Author

Affiliations

UCLouvainAutre

Citations

APA
Chicago
FWB

Delarue, R., Mounier, N., Haioun, C., Coiffier, B., Gisselbrecht, C., Ghesquieres, H., Lederlin, P., Blanc, M., Recher, C., Hermine, O., Reyes, F., Tilly, H., & Bosly, A. (2006). Safety of prophylactic use of darbepoetin alfa in patients with diffuse large B-Cell lymphoma (DLBCL) treated with R-CHOP 14 or RCHOP21: Preliminary results of the LNH03-6B randomized GELA study. Blood, 108(11), 689A. https://hdl.handle.net/2078.5/139453 (Original work published 2006)